Noor Ul Ain Rehman
Thu, April 2, 2026 astatine 9:46 AM CDT 1 min read
Bristol-Myers Squibb Company (NYSE:BMY) besides reported that Camzyos demonstrated meaningful betterment implicit placebo successful aggregate secondary endpoints astatine 28 weeks, adding that akin information findings were observed successful the Camzyos and placebo groups. Management stated that the information is being presented arsenic a late-breaking objective proceedings presumption astatine the American College of Cardiology’s (ACC) Annual Scientific Session & Expo 2026, with simultaneous work successful The New England Journal of Medicine.
Bristol-Myers Squibb Company (NYSE:BMY) is simply a biopharmaceutical institution that discovers, develops, and delivers precocious medicines for superior diseases. Its medicines autumn into assorted therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.
While we admit the imaginable of BMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 hours ago
1





English (CA) ·
English (US) ·
Spanish (MX) ·